These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22818728)

  • 1. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.
    van Calcar SC; Ney DM
    J Acad Nutr Diet; 2012 Aug; 112(8):1201-10. PubMed ID: 22818728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional management of PKU with glycomacropeptide from cheese whey.
    Ney DM; Gleason ST; van Calcar SC; MacLeod EL; Nelson KL; Etzel MR; Rice GM; Wolff JA
    J Inherit Metab Dis; 2009 Feb; 32(1):32-9. PubMed ID: 18956251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU.
    Lim K; van Calcar SC; Nelson KL; Gleason ST; Ney DM
    Mol Genet Metab; 2007; 92(1-2):176-8. PubMed ID: 17644019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and use of glycomacropeptide for nutritional management of phenylketonuria.
    Laclair CE; Ney DM; MacLeod EL; Etzel MR
    J Food Sci; 2009; 74(4):E199-206. PubMed ID: 19490325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
    van Calcar SC; MacLeod EL; Gleason ST; Etzel MR; Clayton MK; Wolff JA; Ney DM
    Am J Clin Nutr; 2009 Apr; 89(4):1068-77. PubMed ID: 19244369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.
    MacLeod EL; Clayton MK; van Calcar SC; Ney DM
    Mol Genet Metab; 2010 Aug; 100(4):303-8. PubMed ID: 20466571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
    MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
    Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uniformity of Food Protein Interpretation Amongst Dietitians for Patients with Phenylketonuria (PKU): 2020 UK National Consensus Statements.
    Evans S; Adam S; Adams S; Allen H; Ashmore C; Bailey S; Banks J; Churchill H; Cochrane B; Cook J; Dale C; Daly A; Dixon M; Dunlop C; Ellerton C; Emm A; Firman S; Ford S; French M; Gribben J; Grimsley A; Herlihy I; Hill M; Judd S; Lang K; Males J; McDonald J; McStravick N; Millington C; Newby C; Noble C; Pereira R; Pinto A; Robertson L; Robotham A; Ross K; Singleton K; Skeath R; Terry A; Van Wyk K; White F; White L; Wildgoose J; Woodall A; MacDonald A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycomacropeptide: A comprehensive understanding of its major biological characteristics and purification methodologies.
    Ebrahimi A; Andishmand H; Huo C; Amjadi S; Khezri S; Hamishehkar H; Mahmoudzadeh M; Kim KH
    Compr Rev Food Sci Food Saf; 2024 May; 23(3):e13370. PubMed ID: 38783570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
    Pena MJ; Pinto A; Daly A; MacDonald A; Azevedo L; Rocha JC; Borges N
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weaning infants with phenylketonuria: a review.
    MacDonald A; Evans S; Cochrane B; Wildgoose J
    J Hum Nutr Diet; 2012 Apr; 25(2):103-10. PubMed ID: 21819461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.